Literature DB >> 19376313

Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.

Alexander R Opotowsky1, Michael J Landzberg, Stephen E Kimmel, Gary D Webb.   

Abstract

BACKGROUND: Percutaneous closure of patent foramen ovale/atrial septal defect (PFO/ASD) is an increasingly common procedure perceived as having minimal risk. There are no population-based estimates of in-hospital adverse event rates of percutaneous PFO/ASD closure.
METHODS: We used nationally representative data from the 2001-2005 Nationwide Inpatient Sample to identify patients >or-=20 years old admitted to an acute care hospital with an International Classification of Diseases, Ninth Revision code designating percutaneous PFO/ASD closure on the first or second hospital day. Variables analyzed included age, sex, number of comorbidities, year, same-day use of intracardiac or other echocardiography, same-day left heart catheterization, hospital size and teaching status, PFO/ASD procedural volume, and coronary intervention volume. Outcomes of interest included length of stay, charges, and adverse events.
RESULTS: The study included 2,555 (weighted to United States population: 12,544 +/- 1,987) PFO/ASD closure procedures. Mean age was 52.0 +/- 0.4 years, and 57.3% +/- 1.0% were women. Annual hospital volume averaged 40.8 +/- 7.7 procedures (range, 1-114). Overall, 8.2 +/- 0.8% of admissions involved an adverse event. Older patients and those with comorbidities were more likely to sustain adverse events. Use of intracardiac echocardiography was associated with fewer adverse events. The risk of adverse events was inversely proportional to annual hospital volume (odds ratio [OR] 0.91, 95% confidence interval [CI] 0.86-0.96, per 10 procedures), even after limiting the analysis to hospitals performing >or=10 procedures annually (OR 0.91, 95% CI 0.85-0.98). Adverse events were more frequent at hospitals in the lowest volume quintile as compared with the highest volume quintile (13.3% vs 5.4%, OR 2.42, 95% CI 1.55-3.78).
CONCLUSIONS: The risk of adverse events of percutaneous PFO/ASD closure is inversely correlated with hospital volume. This relationship applies even to hospitals meeting the current guidelines, performing >or=10 procedures annually.

Entities:  

Mesh:

Year:  2009        PMID: 19376313     DOI: 10.1016/j.ahj.2009.02.019

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Clinical advantage of real-time three-dimensional transesophageal echocardiography for transcatheter closure of multiple atrial septal defects.

Authors:  Manabu Taniguchi; Teiji Akagi; Yasufumi Kijima; Shunji Sano
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-23       Impact factor: 2.357

Review 2.  Influence of hospital volume and outcomes of adult structural heart procedures.

Authors:  Sidakpal S Panaich; Nilay Patel; Shilpkumar Arora; Nileshkumar J Patel; Samir V Patel; Chirag Savani; Vikas Singh; Rajesh Sonani; Abhishek Deshmukh; Michael Cleman; Abeel Mangi; John K Forrest; Apurva O Badheka
Journal:  World J Cardiol       Date:  2016-04-26

3.  Impact of hospital volume on outcomes of percutaneous ASD/PFO closure in pediatric patients.

Authors:  Parth Bhatt; Achint Patel; Varun Kumar; Anusha Lekshminarayanan; Viranchi Patel; Srilatha Alapati; Zeenia Cyrus Billimoria
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

4.  Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.

Authors:  Alexander E Merkler; Gino Gialdini; Shadi Yaghi; Peter M Okin; Costantino Iadecola; Babak B Navi; Hooman Kamel
Journal:  Stroke       Date:  2017-09-22       Impact factor: 7.914

5.  Intracardiac versus transesophageal echocardiography to guide transcatheter closure of interatrial communications: Nationwide trend and comparative analysis.

Authors:  Fahad Alqahtani; Ashwin Bhirud; Sami Aljohani; James Mills; Akram Kawsara; Ashok Runkana; Mohamad Alkhouli
Journal:  J Interv Cardiol       Date:  2017-04-25       Impact factor: 2.279

6.  Recent advances in closure of atrial septal defects and patent foramen ovale.

Authors:  Athar M Qureshi; Larry A Latson
Journal:  F1000 Med Rep       Date:  2010-01-27

7.  The frequency and importance of chest pain in midterm follow up of transcatheter closure of interatrial septal defect.

Authors:  Azin Alizadehasl; Mohsen Neshati Pir Borj; Anita Sadeghpour; Ata Firouzi; Hamidreza Sanati; Masoud Movassaghi
Journal:  J Cardiovasc Thorac Res       Date:  2017-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.